Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg

PartnershipnegativeNegative

AI Analysis

Summary

Bristol Myers Squibb has ended its partnership with Cellares following a comprehensive evaluation, determining the Cell Shuttle system did not meet requirements. Cellares will undergo restructuring as a result of the partnership termination.

Outcome Details

Bristol Myers Squibb ended partnership with Cellares; company determined Cell Shuttle system did not meet requirements

Importance:6/10

Sentiment:

-0.80

partnership dissolutioncell therapyrestructuringmanufacturing

Related Companies

$BMY $CMHSF

Read the original article

Published by Endpoints News on August 25, 2026 12:00 PM

Read Original